WallStreetZenWallStreetZen

NASDAQ: LIPO
Lipella Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for LIPO

Based on 1 analyst offering 12 month price targets for Lipella Pharmaceuticals Inc.
Min Forecast
$2.00+175.86%
Avg Forecast
$2.00+175.86%
Max Forecast
$2.00+175.86%

Should I buy or sell LIPO stock?

Based on 1 analyst offering ratings for Lipella Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LIPO stock forecasts and price targets.

LIPO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-09

1 of 1

LIPO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LIPO$0.73$2.00+175.86%Strong Buy
OGEN$1.01N/AN/A
FRES$0.50N/AN/A
NEXI$3.28N/AN/A
XCUR$0.52N/AN/A

Lipella Pharmaceuticals Stock Forecast FAQ

Is Lipella Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LIPO) stock is to Strong Buy LIPO stock.

Out of 1 analyst, 1 (100%) are recommending LIPO as a Strong Buy, 0 (0%) are recommending LIPO as a Buy, 0 (0%) are recommending LIPO as a Hold, 0 (0%) are recommending LIPO as a Sell, and 0 (0%) are recommending LIPO as a Strong Sell.

If you're new to stock investing, here's how to buy Lipella Pharmaceuticals stock.

What is LIPO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LIPO price target, the average LIPO price target is $2.00, with the highest LIPO stock price forecast at $2.00 and the lowest LIPO stock price forecast at $2.00.

The Wall Street analyst predicted that Lipella Pharmaceuticals's share price could reach $2.00 by Apr 9, 2025. The average Lipella Pharmaceuticals stock price prediction forecasts a potential upside of 175.86% from the current LIPO share price of $0.73.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.